ORTHOPEDIATRICS CORP
Orthopediatrics Corp (KIDS) designs, develops and sells paediatric orthopaedic implants, instruments and biologics tailored to children. The company focuses on smaller anatomies and specialised needs — plates, screws, spinal systems and growth modulation products — and supplies hospitals, surgeons and distributors across multiple markets. Revenue growth is typically driven by new product introductions, increasing surgeon adoption and selective acquisitions, while margins reflect manufacturing, R&D and distribution costs. With a market capitalisation around $449 million, KIDS is a small-cap medical devices company and can be more volatile than larger peers. Key factors to watch include product approvals, clinical outcomes, reimbursement trends, and the effectiveness of commercial roll-outs. Cash position and debt levels will influence its runway for innovation and expansion. This information is general and educational only, not personal advice; investors should assess suitability, perform their own research and be aware that values can fall as well as rise.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Orthopediatrics Corp's stock, expecting its value to rise significantly.
Financial Health
Orthopediatrics Corp is performing well with strong revenue, profits, and cash flow generation.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring KIDS
The Post-Pandemic Pediatric Pivot
The FDA's potential withdrawal of Pfizer's COVID vaccine for young children is reshaping the pediatric pharmaceutical landscape. This regulatory shift could create a significant market opening for other drugmakers focused on pediatric vaccines and therapies.
Published: August 13, 2025
Explore BasketPediatric Vaccine Rollout
This carefully selected group of stocks represents companies positioned to benefit from the full FDA approval of COVID-19 vaccines for at-risk children. Our professional analysts have identified opportunities across the entire value chain, from vaccine manufacturers to healthcare providers and clinical research organizations.
Published: July 11, 2025
Explore BasketNext Generation Economy
Tap into the powerful world of parental spending with these carefully selected stocks. Professional investors have curated this collection of companies that serve children from birth through adolescence, capturing one of the most resilient consumer markets regardless of economic conditions.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Child-focused devices
Specialist products address paediatric needs and can command niche demand, though market uptake varies by surgeon familiarity and evidence.
Innovative pipeline
New product introductions and clinical data may drive adoption, but development and regulatory hurdles can delay commercial benefits.
Global expansion potential
International distribution offers growth opportunities, balanced by reimbursement differences and the costs of scaling operations.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
